Cat. No. ARG43806
The Cybb Knockout RAW 264.7 Cell Line is a CRISPR/Cas9-edited mouse macrophage cell line with targeted disruption of the Cybb gene, which encodes the catalytic NOX2 (gp91phox) subunit of phagocyte NADPH oxidase. This knockout model eliminates the respiratory burst and redox signaling mediated by superoxide and hydrogen peroxide, with key interacting partners including p22phox, p47phox, and Rac GTPases. Derived from the RAW 264.7 monocyte/macrophage line, it is ideal for studying chronic granulomatous disease (CGD), host-pathogen interactions, and ROS-dependent pathways. Applications include ROS detection, phagocytosis and killing assays, cytokine profiling, and screening of NOX2 inhibitors.
| Host Cell | RAW 264.7 |
| Sex of Donor | Male |
| Age | Adult |
| Derived From Site | In situ; Ascites |
| Gene Name | CYBB |
| Gene Identifier | NCBI Gene ID 13058 |
| Growth Mode | Adherent |
| Storage | Liquid nitrogen (LN2) |
| Temperature | 37°C |
| Atmosphere | 5% CO₂ |
| Sterility testing | The bacterial, yeast, and fungi are not detected in these cells by daily monitor. |
| Mycoplasma testing | Negative for mycoplasma through PCR analysis |
Intended Use: This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.
Disclaimer: Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability.
By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use.
This product is provided "AS IS". For Research Use Only. Not for human or animal therapeutic use.
Cybb Knockout RAW 264.7 Cell Line is a CRISPR/Cas9-edited knockout cell line derived from the mouse RAW 264.7 macrophage line, engineered for targeted disruption of the Cybb gene. This genetic modification eliminates functional expression of gp91phox (NOX2), the catalytic subunit of phagocyte NADPH oxidase. The cell line provides a defined loss-of-function model for investigating NOX2-dependent processes without confounding variables from pharmacological inhibition.
RAW 264.7 is a widely used mouse leukemic monocyte/macrophage cell line capable of phagocytosis, cytokine production, and antigen presentation, key features of innate immune responses. These cells respond to Toll-like receptor ligands, Fc receptor engagement, and inflammatory cytokines, making them suitable for studying macrophage signaling pathways. The cell line’s robustness and well-characterized responses to stimuli such as LPS and IFN-?? facilitate reproducible experimental systems.
Cybb encodes gp91phox, the catalytic core of the NOX2 enzyme complex. This complex, assembled with regulatory subunits including p22phox (Cyba), p47phox (Ncf1), p67phox (Ncf2), p40phox (Ncf4), and Rac GTPases, catalyzes the transfer of electrons from NADPH to molecular oxygen, generating superoxide anion. Subsequent dismutation yields hydrogen peroxide, which can be further converted by myeloperoxidase to hypochlorous acid. Upstream activators such as IFN-??, GM-CSF, LPS, TNF-??, and phorbol esters trigger complex assembly and enzyme activation via pathways involving TLR4, Fc?? receptors, and protein kinase C. Downstream effects include activation of redox-sensitive transcription factors NF-??B and AP-1, and production of pro-inflammatory cytokines. Thus, Cybb knockout disrupts both the direct microbicidal respiratory burst and redox-dependent signal transduction.
In RAW 264.7 macrophages, Cybb disruption models X-linked chronic granulomatous disease (CGD), characterized by defective superoxide production and impaired killing of bacteria and fungi. This cell line enables dissection of NOX2 contributions to phagocytosis, intracellular killing, and cytokine responses without the compensatory adaptations seen in whole-organism knockouts. It also allows investigation of non-phagosomal ROS signaling roles of NOX2 in macrophage polarization and inflammatory gene expression.
Typical uses include functional analysis of NOX2 in macrophage biology, host-pathogen interaction studies with bacterial and fungal pathogens, screening of NADPH oxidase inhibitors, and examination of ROS-dependent signaling pathways. Representative assays compatible with this model include luminol-enhanced chemiluminescence for total ROS, DHE fluorescence for superoxide, flow cytometric measurement of respiratory burst using dihydrorhodamine 123, western blotting for gp91phox, phagocytosis and bacterial killing assays, cytokine ELISAs, and NF-??B luciferase reporter gene assays. For further technical details or to request this product, please contact Ascent Research.
